Moneycontrol PRO
you are here: HomeNewsIndia

Over 45 crore COVID-19 vaccine doses administered in India: Govt

Nearly 40 lakh (39,42,457) vaccine doses have been administered on Wednesday, the ministry said citing a provisional report at 7 pm.

July 29, 2021 / 08:22 AM IST
Representative image

Representative image

The cumulative COVID-19 vaccine doses administered in the country have crossed 45 crore with those in the 18-44 age group receiving more than 15.38 crore jabs, the Union Health Ministry said on Wednesday.

Nearly 40 lakh (39,42,457) vaccine doses have been administered on Wednesday, the ministry said citing a provisional report at 7 pm.

The ministry said 20,54,874 vaccine doses were administered as first dose and 3,00,099 as second dose to those in the 18-44 age group on Wednesday.

Cumulatively, 14,66,22,393 persons in the age group 18-44 years across all states and union territories have received their first dose and a total of 71,92,485 have received their second dose since the start of Phase 3 of the vaccination drive.

Five states -- Madhya Pradesh, Gujarat, Rajasthan, Maharashtra and Uttar Pradesh -- have administered more than one crore cumulative doses of COVID-19 vaccine to people in the 18-44 age group, the ministry said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

As on Day-194 of the vaccination drive on Wednesday, a total of 39,42,457 vaccine doses were given.

The ministry said 27,41,794 beneficiaries were vaccinated for the first dose and 12,00,663 beneficiaries received the second dose of vaccine till evening on Wednesday.

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry said.
PTI
first published: Jul 29, 2021 08:23 am
Sections
ISO 27001 - BSI Assurance Mark